Adage Capital Partners Gp, L.L.C. Cabaletta Bio, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,036,645 shares of CABA stock, worth $6.95 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,036,645
Previous 3,036,645
-0.0%
Holding current value
$6.95 Million
Previous $22.7 Million
36.9%
% of portfolio
0.03%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding CABA
# of Institutions
126Shares Held
47.9MCall Options Held
202KPut Options Held
110K-
Jennison Associates LLC5.63MShares$12.9 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$10.9 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY4.12MShares$9.43 Million0.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.67MShares$8.41 Million0.01% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$6.32 Million2.34% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $66.4M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...